Pharmacogenomics & Pharmacoproteomics

Pharmacogenomics & Pharmacoproteomics is the study of the use of genetics in drug response and provided DNA for genomes. It deals with the influence of acquired and inherited genetic variation on drug response in patients by Protein aggregation & stability in biopharmaceuticals, New discoveries in genomic targets, Various drug responses due to genetic polymorphisms, Drug dosage formulations, Drug safety and its efficiency and Membrane transport proteins. There are almost 3000 people from 60-65 universities in USA working for Proteomics. The NIH Pharmacogenomics Research Network (PGRN) is a network of scientists funding to PharmGKB since 2000.

Protein aggregation and stability in biopharmaceuticals, New discoveries in genomic targets, Various drug responses due to genetic polymorphisms, Drug dosage formulations, Drug safety and its efficacy, Membrane transport proteins are the carious topics deals with the Pharmacogenomics & Pharmacoproteomics. It is the study of the role of genetics in drug response and provided DNA for genomes. 

  • Protein aggregation and stability in biopharmaceuticals
  • New discoveries in genomic targets
  • Various drug responses due to genetic polymorphisms
  • Drug dosage formulations
  • Drug safety and its efficacy
  • Membrane transport proteins

Pharmacogenomics & Pharmacoproteomics Conference Speakers